We found that MAGEA3 was highly expressed in UPS/MFS; the expression in these samples was significantly higher than in LMS (p < 0.05), DDLPS (p < 0.001), and synovial sarcoma (p < 0.001). Here, MAGEA3 is linked to synovial sarcoma.